Literature DB >> 2765877

Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro.

J M Barnes1, N M Barnes, B Costall, Z P Horovitz, R J Naylor.   

Abstract

The effects of angiotensin I and II on basal potassium-induced release of [3H]acetylcholine were investigated in slices of rat entorhinal cortex. Potassium (10-25 mM) produced a concentration-dependent increase in the release of [3H]acetylcholine in the presence of extracellular calcium. Angiotensin II (10(-9)-10(-5) M) (but not angiotensin I) reduced the potassium-induced release of [3H]acetylcholine in a concentration-related manner to 60% of control levels, but did not effect basal tritium release. The effect of angiotensin II was antagonised by [1-sarcosine, 8-threonine] angiotensin II, an angiotensin II receptor antagonist, but not by agents acting on alpha- and beta-adrenoceptors, muscarinic, nicotinic, histamine or 5-hydroxytryptamine receptors nor by the angiotensin converting enzyme (ACE) inhibitor SQ 29852. The results indicate that angiotensin II acting via an angiotensin II receptor can inhibit the release of [3H]acetylcholine in slices of the rat entorhinal cortex. It is hypothesised that the ability of ACE inhibitors to facilitate cognitive processes may be related to a reduced availability of angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2765877     DOI: 10.1016/0006-8993(89)90095-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

Review 1.  Nitric oxide and the pancreas: morphological base and role in the control of the exocrine pancreatic secretion.

Authors:  M D Yago; M Mañas; Z Ember; J Singh
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Renin angiotensin system gene polymorphisms modify angiotensin-converting enzyme inhibitors' effect on cognitive function: the health, aging and body composition study.

Authors:  Ihab Hajjar; Stephen Kritchevsky; Anne B Newman; Rongling Li; Kristine Yaffe; Eleanor M Simonsick; Lewis A Lipsitz
Journal:  J Am Geriatr Soc       Date:  2010-06       Impact factor: 5.562

3.  The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial.

Authors:  Whitney Wharton; James H Stein; Claudia Korcarz; Jane Sachs; Sandra R Olson; Henrik Zetterberg; Maritza Dowling; Shuyun Ye; Carey E Gleason; Gail Underbakke; Laura E Jacobson; Sterling C Johnson; Mark A Sager; Sanjay Asthana; Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.

Authors:  Linda Ferrington; Laura E Palmer; Seth Love; Karen J Horsburgh; Paul At Kelly; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2012-04-12       Impact factor: 4.060

6.  Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.

Authors:  Santoshkumar Tota; Kashif Hanif; Pradeep Kumar Kamat; Abul Kalam Najmi; Chandishwar Nath
Journal:  Psychopharmacology (Berl)       Date:  2012-02-24       Impact factor: 4.530

7.  Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Whitney Wharton; Felicia C Goldstein; Liping Zhao; Kyle Steenland; Allan I Levey; Ihab Hajjar
Journal:  J Am Geriatr Soc       Date:  2015-09       Impact factor: 5.562

8.  Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes.

Authors:  J Clapham; G J Kilpatrick
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

Review 9.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

10.  Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo.

Authors:  F H Marshall; S A Clark; A D Michel; J C Barnes
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.